The National Cataract Audit is currently funded through participation fees from centres as well as financial contributions from Alcon, Bausch + Lomb and Rayner.
The Age-Related Macular Degeneration (AMD) Audit is currently part-funded by Roche Products Limited and Bayer plc who have funded the AMD Audit since its commencement.
Roche Products Limited have provided funding to support the conduct of this study. Roche Products Limited has had no further involvement in the project. The project has been supported by an unrestricted, hands-off grant provided by Bayer plc. Bayer plc has no involvement whatsoever in the development or implementation of the project. We are grateful for the funding received from these organisations. We also receive ongoing support through subscription fees from participating hospitals.
